can i use my hsa for tirzepatide HSA/FSA Weight Loss Medication GLP-1s: FSA & HSA Eligibility

It is also crucial to recognize that an increasing number of both preclinical and clinical research studies indicate that some therapeutic benefits of GLP-1 RAs, especially their anti-inflammatory and cytoprotective effects, may not be entirely connected to their primary use related to body weight

A smaller number of individuals report a metallic or altered taste sensation , particularly during the initial weeks of treatment or following dose escalation

At week 68, mean bodyweight change was 14.9% down with semaglutide and 2.4% down with placebo, an estimated treatment difference of 12.4 percentage points

145 PuriP.BaillieR

Methods: Narrative review